MOMs Chat and Care Study for Severe Maternal Morbidity
This study, called the MOMs Chat and Care Study, is testing two different approaches to care for pregnant Black and Hispanic/Latina individuals to reduce the risk of severe maternal morbidity (SMM), which refers to unexpected and serious health problems during or after childbirth. You might be eligible if you are pregnant (less than 17 weeks), identify as Black/African American or Hispanic/Latina, are between 18 and 50 years old, have a certain risk score or history of preeclampsia (high blood pressure during pregnancy), and receive care at Northwell Health. The study will compare two levels of support: 'MOMs High-Touch' and 'MOMs Low-Touch', which include maternal health education resources, telehealth visits, and tools like a home blood pressure monitor and Fitbit. The main goal is to see if these interventions can lower the rate of SMM at labor and delivery, and up to one year postpartum. The study plans to enroll 674 participants.
- Study design
- This is an interventional study that plans to enroll 674 participants. Participants will be randomly assigned to one of two groups: MOMs High-Touch or MOMs Low-Touch.
- What's involved
- You would receive maternal health education resources, potentially up to 12 bi-weekly prenatal telehealth visits, and bi-weekly postpartum telehealth visits until 6 weeks postpartum. You would also use a home blood pressure monitor and a Fitbit throughout the study period.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for severe maternal morbidity at labor and delivery, 1-month postpartum, and 1-year postpartum.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
MOMs Chat and Care Study
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Stephanie L Fitzpatrick, PhD · PRINCIPAL_INVESTIGATOR · Northwell Health
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
What this trial measures
- Severe maternal morbidity (SMM)Labor and delivery; 1-month postpartum; 1-year postpartum
The Centers for Disease Control \& Prevention define SMM as having ≥ 1 ICD-10 diagnosis codes that correspond to 21 SMM indicators. SMM indicator diagnoses that occur at labor and delivery, from delivery to 1-month postpartum during a hospital admission, or from delivery to 1-year postpartum during a hospital admission will be extracted from the electronic health record.